Surprised there been no comments around this collab considering it sounds to be a product with similar mode of action to Cellpryme
immuno-oncology company Imugene and NeoImmuneTech, a T-cell-focused biopharmaceutical company based in Maryland, USA, have come together to evaluate Imugene’s allogeneic CAR T azer-cel in combination with NeoImmuneTech’s proprietary immune T-cell amplifier NT-I7 for the treatment of cancer.Combined, the two treatments are expected to lead to an increase in the number and cancer-fighting properties of a patient’s own T-cells during their treatment with azer-cel.NeoImmuneTech’s NT-I7 is the only long-acting human interleukin-7 (IL-7) cytokine in clinical stage development and has been found to play a key role in T-cell development and survival, boosting cancer fighting T-cell numbers, their health and functionality to enhance immune function and potentially provide improved cancer fighting benefits to patients.
- Forums
- ASX - By Stock
- PTX
- PTX - Banter and General Comments
PTX - Banter and General Comments, page-158
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.1¢ | $5.334K | 126.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 599009 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 599009 | 0.041 |
9 | 480794 | 0.040 |
8 | 657589 | 0.039 |
7 | 938222 | 0.038 |
9 | 883000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 10000 | 1 |
0.044 | 375807 | 3 |
0.045 | 451584 | 5 |
0.046 | 198002 | 2 |
0.047 | 613389 | 3 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |